✅ 8 criteria passed
❌ 3 criteria to solve
Boost genentech-access.com's SEO with Kontactr's Guest Posting.
Secure high-authority, do-follow backlinks from our trusted site—DA44 domain authority and PA55 homepage and blog pages.
Perfect for webmasters seeking higher search rankings and increased organic traffic.
Simple, quick, and effective.
opens a new window
Genentech Access Solutions | Health Care Professionals
http://genentech-access.com
Learn about Genentech Access Solutions, a resource that provides reliable, effective access and reimbursement support to assist your patients and practice.
http://genentech-access.com
Genentech Access Solutions | Health Care Professionals
Learn about Genentech Access Solutions, a resource that provides reliable, effective access and reimbursement support to assist yo...
No 301 redirects are in place to redirect traffic to your preferred domain. Pages that load successfully both with and without www. are treated as duplicate content! Not all versions of your page point to the same URL.
| Attribute | Value |
| ⓘ viewport | width=device-width, initial-scale=1 |
ⓘ The results of our semantic analysis are shown below using the website's language.
They are the main concepts covered by genentech-access.com.
Each concept has a confidence score. The higher it is, the more important the topic is relative to the page.
| Topics | |
Genentech Confidence: 87% 
|
|
Medicine Confidence: 70%
|
|
Patient Confidence: 69%
|
|
Health professional Confidence: 67% 
|
|
|
Accessibility Confidence: 65%
|
✅ genentech-access.com website speed is normal. Page speed is important for visitors and search engines.
Get insights to improve your page loading time.
This domain loads at the median speed of 1.2 seconds.
genentech-access.com is faster than approximately 75 percent of the web. Your website page speed needs to be as fast as you can make it, without compromising the customer experience.
A good goal to achieve is a loading time of 2 seconds on desktop and mobile devices.
ⓘ This website is ranked #4.671.700 by Alexa.
This rank is traffic based. The lower the rank is, the better the domain is ranked.
Mobile Rendering
This website seems to be optimized for Mobile Visitors.
Phone
Tablet
A good text to HTML ratio is anywhere from 25 to 70%.
This percentage refers to the visible text ratio, as opposed to HTML elements, image tags and other non-visible information.
Great, we found headings on this page.
| Top level heading |
| Please select a treatment to continue (2) |
| 2nd level heading |
| Enroll now |
| Patient assistance tool |
| Learn about my patient solutions |
| Genentech access solutions is committed to helping patients access the genentech medicines they need |
| Your email has been sent! |
| 3rd level heading |
| Coverage |
| Reimbursement |
| Product distribution |
| 4th level heading |
| Or select |
| Link to third party site |
| Link to healthcare professionals site |
We found 15 images on this website.
13
ALT attributes are missing on your image tags. The issue affects 12 actual different images that could be loaded more than once in your page.
Alternative text allows you to add a description to an image.
Google rely on alternative text attributes to determine relevance to a search query. Alternative text also makes an image more likely to appear in a Google image search.
It looks like you're missing alternative text for 13 images on genentech-access.com. Check your website to make sure it's specified for each image on the page.
| Anchor | Type | URL |
| For US Healthcare Professionals | text | /hcp.html |
| For Patients and Caregivers | text | /patient.html |
 |
image | /hcp.html |
| Resource Center > | text | /hcp/resource-center.html |
| For Patients or Caregivers | text | /patient.html |
| Learn About Our Services | text | /hcp/learn-about-our-services.html |
| ACTEMRA® (tocilizumab) | text | /hcp/brands/actemra.html |
| ALECENSA® (alectinib) | text | /hcp/brands/alecensa.html |
| AVASTIN® (bevacizumab) | text | /hcp/brands/avastin.html |
| COTELLIC® (cobimetinib) | text | /hcp/brands/cotellic.html |
| ERIVEDGE® (vismodegib) | text | /hcp/brands/erivedge.html |
| ESBRIET® (pirfenidone) | text | /hcp/brands/esbriet.html |
| GAZYVA® (obinutuzumab) | text | /hcp/brands/gazyva.html |
| HEMLIBRA® (emicizumab-kxwh) | text | /hcp/brands/hemlibra.html |
| HERCEPTIN® (trastuzumab) | text | /hcp/brands/herceptin.html |
| HERCEPTIN HYLECTA™ (trastuzumab and hyaluronidase-oysk) | text | /hcp/brands/herceptinhylecta.html |
| KADCYLA® (ado-trastuzumab emtansine) | text | /hcp/brands/kadcyla.html |
| LUCENTIS® (ranibizumab injection) | text | /hcp/brands/lucentis.html |
| OCREVUS® (ocrelizumab) | text | /hcp/brands/ocrevus.html |
| PERJETA® (pertuzumab) | text | /hcp/brands/perjeta.html |
| POLIVY™ (polatuzumab vedotin-piiq) | text | /hcp/brands/polivy.html |
| PULMOZYME® (dornase alfa) Inhalation Solution | text | /hcp/brands/pulmozyme.html |
| RITUXAN® (rituximab) | text | /hcp/brands/rituxan.html |
| RITUXAN HYCELA® (rituximab/hyaluronidase human) | text | /hcp/brands/rituxanhycela.html |
| ROZLYTREK™ (entrectinib) | text | /hcp/brands/rozlytrek.html |
| TARCEVA® (erlotinib) | text | /hcp/brands/tarceva.html |
| TECENTRIQ® (atezolizumab) | text | /hcp/brands/tecentriq.html |
| VENCLEXTA® (venetoclax tablets) | text | /hcp/brands/venclexta.html |
| XOLAIR® (omalizumab) for subcutaneous use | text | /hcp/brands/xolair.html |
| ZELBORAF® (vemurafenib) | text | /hcp/brands/zelboraf.html |
| BIOONCOLOGY | text | /hcp/biooncology.html |
| RHEUMATOLOGY | text | /hcp/rheumatology.html |
| RITUXAN® (rituximab) for Rheumatoid Arthritis (RA) | text | /hcp/brands/rituxan/rituxan-ra.html |
| RITUXAN® (rituximab) for Granulomatosis with Polyangiitis (GPA) and Microscopic Polyangiitis (MPA) | text | /hcp/brands/rituxan/rituxan-gpampa-pv.html |
| RITUXAN® (rituximab) for BioOncology | text | /hcp/brands/rituxan/rituxan-nhl-cll.html |
| RITUXAN® (rituximab) for Pemphigus Vulgaris (PV) | text | /hcp/brands/rituxan/rituxan-pv.html |
 |
image | /hcp/my-patient-solutions.html |
| Anchor | Type | URL |
| My Patient Solutions® | text | https://genentech-prod.force.com/ihcp/gne_cm_pact_login |
 |
image | https://www.gene.com |
| Privacy Policy | text | http://www.gene.com/privacy-policy |
| Terms & Conditions | text | http://www.gene.com/terms-conditions |
| ⓘ Domain Registrar | SAFENAMES LTD |
| ⓘ Registration Date | 04/27/2012 13 years, 9 months, 11 days ago |
| ⓘ Last Modified | 05/01/2018 7 years, 9 months, 7 days ago |
| ⓘ Expiration Date | 04/27/2020 Expired |
| Host | IP Address | Country |
| dnadns2e.gene.com | 72.34.128.76 |  United States |
| dnadns3e.gene.com | 72.34.133.50 | United States |
| dnadns4e.gene.com | 72.34.128.50 | United States |
| Domain |
SOCIAL MEDIA PRESENCE
You're doing quiet good on social media!
Social shares are a key signal, among many others, that search engines use to evaluate the rankings of a website. Asking people to share your pages, adding visible social share buttons and make great quality content are 3 of the most powerful ways to grow your social presence.